IP Library Patent Application 16491234
Patent Application
App. No. 16/491,234

PROCESSES FOR PREPARING PARTIALLY FLUORINATED EPOXIDES AND PERFLUORINATED EPOXIDES AND COMPOSITIONS RELATED THERETO

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/491,234
Abstract

This application relates to the preparation of partially fluorinated epoxides and perfluorinated epoxides which may be useful in various applications including refrigerants, heat transfer media, high-temperature heat pumps, organic Rankine cycles, fire extinguishing/fire suppression, propellants, foam blowing, solvents, gaseous dielectrics, and/or cleaning fluids. Compositions comprising the fluorinated epoxide compounds are also provided.

Claims (146)

1 . A process of preparing a compound of Formula (I):

comprising reacting a compound of Formula (II):

R 1 —C(R 2 )═C(R 3 )—R 4   (II)

with an aqueous hypohalite salt in the presence of a cationic phase transfer catalyst and an organic solvent, wherein:

R 1 and R 4 are each independently H, Cl, F, Br, I, a partially fluorinated C 1-4 alkoxy, or a perfluorinated C 1-4 alkoxy;

R 2 is selected from H, Cl, F, Br, I, a partially fluorinated C 1-10 alkyl, a perfluorinated C 1-10 alkyl, a partially fluorinated C 1-4 alkoxy, and a perfluorinated C 1-4 alkoxy;

wherein at least one of R 1 , R 2 , and R 4 is not H; and

R 3 is selected from partially fluorinated and perfluorinated C 1-10 alkyl;

or alternatively, R 2 and R 3 are each independently selected from partially fluorinated or perfluorinated C 1-5 alkylene, which together form a monocyclic ring.

2 . (canceled)

3 . (canceled)

4 . The process of claim 1 , wherein R 1 and R 4 are each independently H or F; and R 2 and R 3 are each independently selected from partially fluorinated or perfluorinated C 1-10 alkyl.

5 . The process of claim 1 , wherein the hypohalite salt is selected from NaOCl, KOCl, NaOBr, and Ca(OCl) 2 .

6 . (canceled)

7 . The process of claim 1 , wherein the cationic phase transfer catalyst is a quaternary ammonium salt or a quaternary phosphonium salt.

8 . (canceled)

9 . The process of claim 1 , the cationic phase transfer catalyst has formula (R a )(R b )(R c )(R d )N + X − or (R a )(R b )(R c )(R d )P + X − , wherein R a , R b , R c , and R 4 are each independently selected from C 1-18 alkyl, C 3-14 cycloalkyl, 4-14 membered heterocycloalkyl, C 6-14 aryl, 5-14 membered heteroaryl, C 3-14 cycloalkyl-C 1-3 alkylene, 4-14 membered heterocycloalkyl-C 1-3 alkylene, C 6-14 membered aryl-C 1-3 alkylene, and 5-14 membered heteroaryl-C 1-3 alkylene, each of which is optionally substituted by 1, 2, 3, or 4 groups independently selected from OH, C 1-6 alkoxy, C 1-6 alkyl, C 2-6 alkenyl, C 1-6 fluoroalkyl, di-(C 1-6 alkyl)amino, C 3-14 cycloalkyl, 4-14 membered heterocycloalkyl, C 6-14 membered aryl, and 5-14 membered heteroaryl; and X − is an anion.

10 . The process of claim 1 , wherein the cationic phase transfer catalyst has formula (R a )(R b )(R c )(R d )N + X − , wherein R a , R b , R c , and R 4 are eah independently selected from C 1-12 alkyl; and X is a halide ion or HSO 4 − .

11 . The process of claim 1 , wherein the cationic phase transfer catalyst has formula (R a )(R b )(R c )(R d )P + X − , wherein R a , R b , R c , and R d are each independently selected from C 1-12 alkyl or phenyl; and X is a halide ion or HSO 4 − .

12 . (canceled)

13 . The process of claim 1 , wherein the organic solvent is acetonitrile, tetrahydrofuran, diethyl ether, methyl-t-butyl ether, dimethyoxyethane, bis(2-methoxyethyl) ether, or benzene substituted with 1, 2, 3, or 4 independently selected C 1-4 alkyl groups.

14 . The process of claim 1 , wherein the organic solvent is acetonitrile or benzene substituted with 1, 2, 3, or 4 independently selected C 1-4 alkyl groups.

15 . The process of claim 1 , wherein the organic solvent is acetonitrile, toluene, o-xylene, m-xylene, p-xylene or a mixture thereof.

16 . (canceled)

17 . The process of claim 1 , wherein the reaction is conducted at a pH of from 10 to 14.

18 . The process of claim 1 , wherein the reaction is conducted at a temperature of from about 10° C. to about 30° C., from about 10° C. to about 20° C., from about 20° C. to about 30° C., or from about 25° C. to about 30° C.

19 . (canceled)

20 . (canceled)

21 . The process of claim 1 , wherein the compound of Formula (I) is selected from the group consisting of:

(Z)-2,3-difluoro-2-(trifluoromethyl)oxirane;

(E)-2,3-difluoro-2-(trifluoromethyl)oxirane;

cis-2-fluoro-3-(trifluoromethyl)oxirane;

trans-2-fluoro-3-(trifluoromethyl)oxirane;

trans-2,3-bis(trifluoromethyl)oxirane;

cis-2,3-bis(trifluoromethyl)oxirane;

trans-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

trans-2-(trifluoromethyl)-3-(perfluoropropan-2-yl)oxirane;

trans-2,3-bis(perfluoropropyl)oxirane;

trans-2-(perfluorobutyl)-3-(perfluoroethyl)oxirane;

trans-2,3-bis(perfluorobutyl)oxirane;

(Z)-2-(2,2,2-Trifluoroethoxy)-3-fluoro-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

(E)-2-(2,2,2-Trifluoroethoxy)-3-fluoro-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

cis-2,3-dichloro-2,3-bis(trifluoromethyl)oxirane;

trans-2,3-dichloro-2,3-bis(trifluoromethyl)oxirane;

trans-2-fluoro-3-(perfluoropropan-2-yl)oxirane;

cis-2-fluoro-3-(perfluoropropan-2-yl)oxirane;

cis-2,2,3,3,4,4-hexafluoro-6-oxa-bicyclo[3.1.0]hexane;

cis-2,2,3,3-tetrafluoro-5-oxabicyclo[2.1.0]pentane;

cis-2,3-difluoro-2-(perfluoroethyl)-3-(perfluoropropyl)oxirane;

trans-2,3-difluoro-2-(perfluoroethyl)-3-(perfluoropropyl)oxirane;

cis-2,3-difluoro-2-(trifluoromethyl)-3-(perfluoropentyl)oxirane; and

trans-2,3-difluoro-2-(trifluoromethyl)-3-(perfluoropentyl)oxirane.

22 . A composition comprising a compound of Formula I:

R 1 and R 4 are each independently H, Cl, F, Br, I, a partially fluorinated C 1-4 alkoxy, or a perfluorinated C 1-4 alkoxy;

R 2 is selected from H, Cl, F, Br, I, a partially fluorinated C 1-10 alkyl, a perfluorinated C 1-10 alkyl, a partially fluorinated C 1-4 alkoxy, and a perfluorinated C 1-4 alkoxy;

wherein at least one of R 1 , R 2 , and R 4 is not H; and

R 3 is selected from partially fluorinated and perfluorinated C 1-10 alkyl;

or alternatively, R 2 and R 3 are each independently selected from partially fluorinated or perfluorinated C 1-5 alkylene, which together form a monocyclic ring;

wherein the compound of Formula I has the (Z) or (E) configuration and the composition is substantially free of the opposite stereoisomers.

23 . A composition of claim 22 , wherein the composition comprises a compound selected from:

(Z)-2,3-difluoro-2-(trifluoromethyl)oxirane;

(E)-2,3-difluoro-2-(trifluoromethyl)oxirane;

cis-2-fluoro-3-(trifluoromethyl)oxirane;

trans-2-fluoro-3-(trifluoromethyl)oxirane;

trans-2,3-bis(trifluoromethyl)oxirane;

cis-2,3-bis(trifluoromethyl)oxirane;

trans-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

trans-2-(trifluoromethyl)-3-(perfluoropropan-2-yl)oxirane;

trans-2,3-bis(perfluoropropyl)oxirane;

trans-2-(perfluorobutyl)-3-(perfluoroethyl)oxirane;

trans-2,3-bis(perfluorobutyl)oxirane;

(Z)-2-(2,2,2-Trifluoroethoxy)-3-fluoro-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

(E)-2-(2,2,2-Trifluoroethoxy)-3-fluoro-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

cis-2,3-dichloro-2,3-bis(trifluoromethyl)oxirane;

trans-2,3-dichloro-2,3-bis(trifluoromethyl)oxirane;

trans-2-fluoro-3-(perfluoropropan-2-yl)oxirane;

cis-2-fluoro-3-(perfluoropropan-2-yl)oxirane;

cis-2,2,3,3,4,4-hexafluoro-6-oxa-bicyclo[3.1.0]hexane;

cis-2,2,3,3-tetrafluoro-5-oxabicyclo[2.1.0]pentane;

cis-2,3-difluoro-2-(perfluoroethyl)-3-(perfluoropropyl)oxirane;

trans-2,3-difluoro-2-(perfluoroethyl)-3-(perfluoropropyl)oxirane;

cis-2,3-difluoro-2-(trifluoromethyl)-3-(perfluoropentyl)oxirane; and

trans-2,3-difluoro-2-(trifluoromethyl)-3-(perfluoropentyl)oxirane.

24 . A compound selected from the group consisting of:

(Z)-2,3-difluoro-2-(trifluoromethyl)oxirane;

(E)-2,3-difluoro-2-(trifluoromethyl)oxirane;

cis-2-fluoro-3-(trifluoromethyl)oxirane;

trans-2-fluoro-3-(trifluoromethyl)oxirane;

trans-2,3-bis(trifluoromethyl)oxirane;

cis-2,3-bis(trifluoromethyl)oxirane;

trans-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

trans-2-(trifluoromethyl)-3-(perfluoropropan-2-yl)oxirane;

trans-2,3-bis(perfluoropropyl)oxirane;

trans-2-(perfluorobutyl)-3-(perfluoroethyl)oxirane;

trans-2,3-bis(perfluorobutyl)oxirane;

(Z)-2-(2,2,2-Trifluoroethoxy)-3-fluoro-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

(E)-2-(2,2,2-Trifluoroethoxy)-3-fluoro-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane;

cis-2,3-dichloro-2,3-bis(trifluoromethyl)oxirane;

trans-2,3-dichloro-2,3-bis(trifluoromethyl)oxirane;

trans-2-fluoro-3-(perfluoropropan-2-yl)oxirane;

cis-2-fluoro-3-(perfluoropropan-2-yl)oxirane;

cis-2,2,3,3,4,4-hexafluoro-6-oxa-bicyclo[3.1.0]hexane;

cis-2,2,3,3-tetrafluoro-5-oxabicyclo[2.1.0]pentane;

cis-2,3-difluoro-2-(perfluoroethyl)-3-(perfluoropropyl)oxirane;

trans-2,3-difluoro-2-(perfluoroethyl)-3-(perfluoropropyl)oxirane;

cis-2,3-difluoro-2-(trifluoromethyl)-3-(perfluoropentyl)oxirane; and

trans-2,3-difluoro-2-(trifluoromethyl)-3-(perfluoropentyl)oxirane.

25 . A composition comprising a compound of Formula (I):

and a compound of Formula (III):

R 5 —C(R 6 )═C(R 7 )—R 8   (III)

wherein:

the compounds of Formula (I) and Formula (III) have the same stereochemistry;

R 1 and R 5 are identical and are H, Cl, F, Br, I, a partially fluorinated C 1-4 alkoxy, or a perfluorinated C 1-4 alkoxy;

R 4 and R 8 are identical and each independently H, Cl, F, Br, I, a partially fluorinated C 1-4 alkoxy, or a perfluorinated C 1-4 alkoxy;

R 2 and R 6 are identical and are Cl, F, Br, I, partially fluorinated C 1-10 alkyl, or perfluorinated C 1-10 alkyl; and

R 3 and R 7 are identical and are partially fluorinated or perfluorinated C 1-10 alkyl; provided that either R 1 and R 5 are H or Cl; or R 4 and R 8 are H or Cl.

26 . A composition comprising a compound of Formula (I):

and a compound of Formula (III):

R 5 —C(R 6 )═C(R 7 )—R 8   (III)

wherein:

the compounds of Formula (I) and Formula (III) have the same stereochemistry;

R 1 and R 5 are identical and are H, Cl, F, Br, I, a partially fluorinated C 1-4 alkoxy, or a perfluorinated C 1-4 alkoxy;

R 4 and R 8 are identical and each independently H, Cl, F, Br, I, a partially fluorinated C 1-4 alkoxy, or a perfluorinated C 1-4 alkoxy;

R 2 and R 6 are identical and are partially fluorinated or perfluorinated C 1-5 alkylene; and

R 3 and R 7 are identical and are partially fluorinated or perfluorinated C 1-5 alkylene; wherein said R 2 and R 3 are taken together form a monocyclic ring and R 6 and R 7 are taken together form a monocyclic ring;

27 . The composition of claim 25 , wherein the molar ratio of the compound of Formula (I) to the compound of Formula (III) in the composition is from about 50:50 to about 99.:0.01

28 . (canceled)

29 . (canceled)

30 . The composition of claim 25 , wherein the composition comprises:

a compound of Formula (I) which is 2-fluoro-3-(trifluoromethyl)oxirane and a compound of Formula (III) which is 1,3,3,3-tetrafluoroprop-1-ene; or

a compound of Formula (I) which is 2,3-bis(trifluoromethyl)oxirane and a compound of Formula (III) which is 1,1,1,4,4,4-hexafluorobut-2-ene; or

a compound of Formula (I) which is 2-(trifluoromethyl)-3-(perfluoroethyl)oxirane and a compound of Formula (III) which is 1,1,1,4,4,5,5,5-octafluoropent-2-ene; or

a compound of Formula (I) which is 2-(trifluoromethyl)-3-(perfluoropropan-2-yl)oxirane and a compound of Formula (III) which is 1,1,1,5,5,5-hexafluoro-4,4-bis(trifluoromethyl)pent-2-ene; or

a compound of Formula (I) which is 2,3-bis(perfluoropropyl)oxirane and a compound of Formula (III) which is 1,1,1,2,2,3,3,6,6,7,7,8,8,8-tetradecafluorooct-4-ene; or

a compound of Formula (I) which is 2-(perfluorobutyl)-3-(perfluoroethyl)oxirane and a compound of Formula (III) which is 1,1,1,2,2,5,5,6,6,7,7,8,8,8-tetradecafluorooct-3-ene; or

a compound of Formula (I) which is 2,3-bis(perfluorobutyl)oxirane and a compound of Formula (III) which is 1,1,1,2,2,3,3,4,4,7,7,8,8,9,9,10,10,10-octadecafluorodec-5-ene; or

a compound of Formula (I) which is 2-(2,2,2-Trifluoroethoxy)-3-fluoro-2-(trifluoromethyl)-3-(perfluoroethyl)oxirane and a compound of Formula (III) which is 2-(2,2,2-trifluoroethoxy)-1,1,1,4,4,5,5,5-octafluoropent-2-ene; or

a compound of Formula (I) which is 2,3-dichloro-2,3-bis(trifluoromethyl)oxirane and a compound of Formula (III) which is 2,3-dichloro-1,1,1,4,4,4-hexafluorobut-2-ene; or

a compound of Formula (I) which is 2-fluoro-3-(perfluoropropan-2-yl)oxirane and a compound of Formula (III) which is 1,3,4,4,4-pentafluoro-3-(trifluoromethyl)but-1-ene; or

a compound of Formula (I) which is 2,3-difluoro-2-(perfluoroethyl)-3-(perfluoropropyl)oxirane and a compound of Formula (III) which is perfluoroheptene-3; or

a compound of Formula (I) which is 2,3-difluoro-2-(trifluoromethyl)-3-(perfluoropentyl)oxirane and a compound of Formula (III) which is perfluoroctene-2.

31 . The composition of claim 26 , wherein the composition comprises:

a compound of Formula (I) which is 2,2,3,3,4,4-hexafluoro-6-oxa-bicyclo[3.1.0]hexane and a compound of Formula (III) which is 3,3,4,4,5,5-hexafluorocyclopent-1-ene; or

a compound of Formula (I) which is 2,2,3,3-tetrafluoro-5-oxabicyclo[2.1.0]pentane and a compound of Formula (III) which is 3,3,4,4-tetrafluorocyclobut-1-ene.

32 . (canceled)

33 . (canceled)

Assignments (2)
PATENT SECURITY AGREEMENT Recorded May 7, 2020
From: THE CHEMOURS COMPANY FC, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052598/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2019
From: PETROV, VIACHESLAV A.; BRANDT, DREW RICHARD
To: THE CHEMOURS COMPANY FC, LLC
Reel/Frame 050277/0753 →